Navigation Links
Vital Images Surpasses 3,000 Customer Sites Worldwide
Date:4/30/2008

Pioneer in Advanced Visualization Solutions Has Become Worldwide Imaging Leader with Focus on Enterprise-wide Access and Clinical Collaboration

MINNEAPOLIS, April 30 /PRNewswire-FirstCall/ -- Vital Images, Inc. (Nasdaq: VTAL), a worldwide leader of enterprise-wide advanced visualization and analysis solutions, has surpassed the milestone of 3,000 customers, approximately 5,000 installations and thousands more users worldwide of advanced visualization software solutions.

"We are very proud of reaching this customer milestone and committed to continued delivery of advanced visualization solutions and collaboration tools that can be quickly and easily integrated into daily medical practice," said Michael H. Carrel, Vital Images president and chief executive officer. "We have strong, collaborative relationships with our customers based on the common goal of enterprise-wide access of advanced visualization solutions designed to improve the impact and delivery of patient care."

Vital Images values relationships and has invested in programs and technology designed to enhance relationships between customers, referring physicians, partners and patients. Building on its knowledge and understanding of complex clinical workflow, Vital Images offers a comprehensive suite of enterprise-wide advanced visualization and connectivity solutions.

"I have been a Vital Images user since 1999 and originally selected the ViTAL solution because it was ground breaking in its ability to provide fast, powerful and intuitive clinical information," said Lawrence Neil Tannenbaum, MD, FACR, director of CT and MR Imaging, Mount Sinai Medical Center in New York City. "Our experience with ViTAL has evolved from a user-vendor relationship to a t
'/>"/>

SOURCE Vital Images, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Alliance for Wellness ROI, Inc. Selects VitalSpring as Exclusive Technology Partner
2. Atherosclerosis May Also Harm Vital Organs
3. New Patient Monitoring Devices Handle More Than Just Vital Signs
4. Dr. Robert CJ Krasner Appointed to Vitals.com as Independent Advisor
5. Vital Images Comments on CMS Decision to Allow Local Coverage for Cardiac CT Angiography
6. Vital Health Technologies, Inc. / Caribbean American Health Resorts Inc. Acquires Momentum Medical Group, Inc.
7. Super Charge the Skin with Murad Vitalic(R) Featuring Energizing Pomegranate Complex(TM)
8. Appropriate medical screening for antimalarials vital to US military personnel
9. Congressman Buchanan Tours Florida Clinical Laboratory; Learns Vital Role in Patient Care
10. Congressman Altmire Tours Womens Health Clinical Laboratory; Learns Vital Role in Patient Care
11. K-State Trauma Researcher Says Being Prepared, Taking Action Are Vital in Preventing Tragedies Like the One at NIU
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Negative Pressure Wound Devices Draw FDA Notice, Advice 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Photo 3A Poor Disabled Children in Ecuador Receive Free Wheelchairs 21 56135 1Photo 3A Poor Disabled Children in Ecuador Receive Free Wheelchairs 21 56135 2Photo 3A Poor Disabled Children in Ecuador Receive Free Wheelchairs 21 56135 3Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 1Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 2Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 1Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 2
Other Medicine Technology:Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 2Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 3Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 4Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 5OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 2OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 3OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 4